Although the optimal stimulation target for deep brain stimulation in MDS is unclear, emerging evidence from clinical and basic studies have indicated the GPi or Vim may be the potential targets for DBS in the management of MDS. The gene discussed is GPI; the disease is myelodysplastic syndrome.